IL150286A0 - Treatment of dna viral infections - Google Patents

Treatment of dna viral infections

Info

Publication number
IL150286A0
IL150286A0 IL15028600A IL15028600A IL150286A0 IL 150286 A0 IL150286 A0 IL 150286A0 IL 15028600 A IL15028600 A IL 15028600A IL 15028600 A IL15028600 A IL 15028600A IL 150286 A0 IL150286 A0 IL 150286A0
Authority
IL
Israel
Prior art keywords
treatment
viral infections
dna viral
dna
useful
Prior art date
Application number
IL15028600A
Other languages
English (en)
Original Assignee
Henderson Morley Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930811.6A external-priority patent/GB9930811D0/en
Priority claimed from GB0000683A external-priority patent/GB0000683D0/en
Priority claimed from GB0023198A external-priority patent/GB0023198D0/en
Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd
Publication of IL150286A0 publication Critical patent/IL150286A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL15028600A 1999-12-30 2000-12-13 Treatment of dna viral infections IL150286A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9930811.6A GB9930811D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023198A GB0023198D0 (en) 1999-12-30 2000-09-21 Treatment of DNA viral infections
PCT/GB2000/004793 WO2001049242A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Publications (1)

Publication Number Publication Date
IL150286A0 true IL150286A0 (en) 2002-12-01

Family

ID=27255465

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15028600A IL150286A0 (en) 1999-12-30 2000-12-13 Treatment of dna viral infections

Country Status (17)

Country Link
US (1) US6894030B2 (de)
EP (1) EP1242119B1 (de)
JP (1) JP2003519163A (de)
KR (1) KR100843790B1 (de)
CN (1) CN1414863A (de)
AT (1) ATE261737T1 (de)
AU (1) AU777339B2 (de)
BR (1) BR0016831A (de)
CA (1) CA2395016C (de)
DE (1) DE60009146T2 (de)
DK (1) DK1242119T3 (de)
ES (1) ES2218254T3 (de)
IL (1) IL150286A0 (de)
MX (1) MXPA02006489A (de)
PT (1) PT1242119E (de)
TR (1) TR200401363T4 (de)
WO (1) WO2001049242A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
GB2376628B (en) * 2001-06-19 2005-06-08 Henderson Morley Res & Dev Ltd Treatment of DNA viral infections in cats
ATE435019T1 (de) * 2000-09-21 2009-07-15 Henderson Morley Res & Dev Ltd Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment
US7534768B2 (en) * 2000-12-13 2009-05-19 Henderson Morely Research And Development Ltd. Treatment of DNA viral infections
WO2003099011A1 (en) * 2002-05-28 2003-12-04 Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
MXPA05008527A (es) 2003-02-12 2006-03-08 Univ Georgetown Uso de artemisinina para tratar tumores inducidos por virus oncogenicos y para tratar infecciones virales.
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
JP2009511629A (ja) * 2005-10-17 2009-03-19 ニューロセラピューティクス ファーマ， インコーポレイテッド 中枢神経系疾患の調節に有用な利尿薬様化合物類似体
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections
CN106562982A (zh) * 2016-09-27 2017-04-19 苏州系统医学研究所 强心苷类化合物在抗埃博拉病毒感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03240732A (ja) * 1990-02-14 1991-10-28 Yasuo Tanaka 抗ウイルス剤
US7071230B2 (en) * 1997-10-02 2006-07-04 Board Of Trustees Of Southern Illinois University Therapeutic use of D-methionine to reduce the toxicity of noise
WO2000010574A1 (en) * 1998-08-24 2000-03-02 Hadasit Medical Research Services And Development Ltd. The use of loop diuretics for hiv infection
ATE306275T1 (de) * 1999-12-30 2005-10-15 Henderson Morley Res & Dev Ltd Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Also Published As

Publication number Publication date
EP1242119A2 (de) 2002-09-25
WO2001049242A3 (en) 2002-07-11
CN1414863A (zh) 2003-04-30
DE60009146T2 (de) 2005-02-17
CA2395016A1 (en) 2001-07-12
KR20030005162A (ko) 2003-01-17
US20030050253A1 (en) 2003-03-13
TR200401363T4 (tr) 2004-08-23
AU1873401A (en) 2001-07-16
PT1242119E (pt) 2004-08-31
CA2395016C (en) 2009-04-14
DE60009146D1 (de) 2004-04-22
MXPA02006489A (es) 2003-09-22
AU777339B2 (en) 2004-10-14
JP2003519163A (ja) 2003-06-17
EP1242119B1 (de) 2004-03-17
KR100843790B1 (ko) 2008-07-03
WO2001049242A2 (en) 2001-07-12
ES2218254T3 (es) 2004-11-16
DK1242119T3 (da) 2004-08-02
US6894030B2 (en) 2005-05-17
ATE261737T1 (de) 2004-04-15
BR0016831A (pt) 2002-09-10

Similar Documents

Publication Publication Date Title
MXPA02006489A (es) Tratamiento para infecciones dna virales.
EP0831873A4 (de) Die behandlung von hiv und anderen viralen infektionen mit der kombinationstherapie
PL308122A1 (en) Viral vectors and their application in genic therapy
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
MY108638A (en) Antiviral nucleoside combination.
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
GR3024699T3 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections.
AU1539699A (en) Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
CA95630S (en) Cabinet
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
MD990258A (en) Method of treatment of the acute viral hepatitis B
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
PL356640A1 (en) Treatment of viral infections using levovirintm
AU1873101A (en) Synergistic treatment of dna viral infections
MY124071A (en) Treatment of viral disease in swine
AU2001287907A1 (en) Diuretic or sulphonylurea for use in antiviral treatment
GB9603657D0 (en) Improvements in the treatment of vaginal infections
EP1143981A4 (de) Behandlung und vorbeugung von hiv- und anderen virus infektionen
PL350577A1 (en) Treatment of chronic viral infections with m. vaccae
MXPA02000485A (es) 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple.
GB9723824D0 (en) Cytostatic agents
Zhang Effect of ribavirin on acute and persistent human coronavirus infection, in vitro.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees